The cause of Parkinson’s is unknown, but a distinctive characteristic of the disease is a reduction in the amount of the neurotransmitter dopamine in the brain. Dopamine is essential in regulating movement and emotional responses.
Dopamine production is stimulated by cannabis. Indeed, it’s believed this increase in dopamine is at least partially responsible for the euphoric effects associated with cannabis consumption. This has led researchers to conduct preliminary experiments to examine the relationship between cannabis, dopamine, and Parkinson’s. (See links to some of these projects below.)
Tuesday, April 11th is World Parkinson’s Day. Please join us in supporting this most worthwhile effort to raise awareness and promote understanding of this debilitating and alarmingly widespread malady.
Medical Cannabis and Parkinson’s: Research
- Cannabis (Medical Marijuana) Treatment for Motor and Non-Motor Symptoms of Parkinson Disease: An Open-Label Observational Study
- Cannabis for dyskinesia in Parkinson disease
- Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson’s disease